Literature DB >> 29422361

Primary diffuse leptomeningeal melanomatosis: Description and recommendations.

Yamaan S Saadeh1, Todd C Hollon1, Amanda Fisher-Hubbard2, Luis E Savastano1, Paul E McKeever2, Daniel A Orringer3.   

Abstract

Primary melanocytic disease of the central nervous system is a rarely encountered condition currently without consensus on treatment and lacking major guidelines for management. Understanding the nature of the disease and differentiating primary melanocytic disease from the much more commonly encountered secondary (metastatic) melanoma is important in identifying the condition and pursuing appropriate treatment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central nervous system; Hydrocephalus; Leptomeningeal melanomatosis; Melanocytic disease

Mesh:

Year:  2018        PMID: 29422361     DOI: 10.1016/j.jocn.2018.01.052

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report.

Authors:  Ana Misir Krpan; Zoran Rakusic; Davorin Herceg
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.